Uptick In Mass Tort Advertising

Per a safety warning from the FDA issued on May 3rd, 2016, Kantar Media’s CMAG has monitored a new spot in the Miami market, airing today, May 9th, on WSFL [CW affiliate] at 6:19AM.

CMAG has seen a noticeable uptick in mass tort advertising targeting users of Otsuka Pharmaceutical’s Abilify; from $7K in January up to $267K in April. This drug, prescribed to treat mental health disorders such as schizophrenia and depression, is alleged to cause compulsive behaviors such as gambling, binge eating and binge shopping.

Interested in learning more? You can get insights just like this from Kantar Media's Campaign Media Analysis Group (CMAG) law firm ad monitoring service. CMAG delivers real-time, accurate information on where TV ads are airing, what they say, how much is being spent, and the actual creative for viewing. Our experts provide clients with actionable insights to inform critical decision making. Contact us today to discover how we can help you!

Search article

You might also be interested in...

Will lawyers boost immigration reform again in 2016?
Read more
Political: fast, actionable advertising intelligence
Read more